Information för alternativet: Zomig Rapimelt 2,5 Mg Munsönderfallande Tablett, Zomig Rapimelt 5 Mg Munsönderfallande Tablett, visa andra alternativ

Välj alternativ:

1. Zomig Rapimelt 2,5 Mg Munsönderfallande Tablett Zomig Rapimelt 5 Mg Munsönderfallande Tablett
2. Zomig Rapimelt 2,5 Mg Munsönderfallande Tablett

Document: Zomig Rapimelt orodispersible tablet ENG PL change

• Zomig Rapimelt orodispersible tablet PL
• Zomig Rapimelt orodispersible tablet OTC PL
• Zomig Rapimelt orodispersible tablet ENG PL

---

PACKAGE LEAFLET: INFORMATION FOR THE USER

Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets

Zolmitriptan

Read all of this leaflet carefully before you start taking this medicine.

• Keep this leaflet. You may need to read it again.

• If you have any further questions, ask your doctor or pharmacist.

• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. See section 4.

In this leaflet:

1. What Zomig Rapimelt is and what it is used for

2. Before you take Zomig Rapimelt

3. How to take Zomig Rapimelt

4. Possible side effects

6. Further information

Zomig Rapimelt contains zolmitriptan and belongs to a group of medicines called triptans.

Zomig Rapimelt is used to treat migraine headache.

Do not take Zomig Rapimelt if:

- you are allergic (hypersensitive) to zolmitriptan or any of the other ingredients of this medicine (see Section 6: Further Information)

- you have high blood pressure

- you have ever had heart problems, including a heart attack, angina (chest pain caused by exercise or effort), Prinzmetal’s angina (chest pain which happens at rest) or have experienced heart related symptoms such as shortness of breath or pressure over the chest

- you have had a stroke or short-lasting symptoms similar to stroke (transient ischaemic attack or TIA)

- you have severe kidney problems

- you are at the same time taking some other medicines for migraine (e.g. ergotamine or ergot-type medicines like dihydroergotamine and methysergide) or other triptan medicines for migraine. See section below: ‘Taking other medicines’ for further information.

If you are not sure if any of these apply to you, talk to your doctor or pharmacist.

Take special care with Zomig Rapimelt

Before you take Zomig Rapimelt, tell your doctor if:

- you are at risk of getting ischaemic heart disease (poor blood flow in the arteries of the heart). Your risk is greater if you smoke, have high blood pressure, high levels of cholesterol, diabetes or if anyone in your family has ischeamic heart disease

- you have been told that you have Wolff-Parkinson-White Syndrome (a type of abnormal heart beat)

- you have ever had liver problems

• you have headaches which are not like your usual migraine headache

• you are taking any other medicine for treatment of depression (see ‘Taking other medicines’ later in this section).

If you go into hospital tell the medical staff you are taking Zomig Rapimelt.

Zomig Rapimelt is not recommended for people aged under 18 years or over 65.

As with other migraine treatments, using too much Zomig Rapimelt can cause daily headaches or can make you migraine headaches worse. Ask your doctor if you think that this is the case for you. You may need to stop using Zomig Rapimelt to correct the problem.

Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes herbal medicines and medicines you buy without prescription.

In particular, tell your doctor if you are taking any of the following medicines:

Medicines for migraine

• If you take triptans other than Zomig Rapimelt, leave 24 hours before taking Zomig Rapimelt.

• After taking Zomig Rapimelt leave 24 hours before taking triptans other than Zomig Rapimelt.

• If you take medicines containing ergotamine or ergot-type medicines (such as dihydroergotamine or methysergide), leave 24 hours before taking Zomig Rapimelt.

• After taking Zomig Rapimelt leaves 6 hours before taking ergotamine or ergot-type medicines.

Medicines for depression

• moclobemide or fluvoxamine

• medicines called SSRIs (selective serotonin reuptake inhibitors)

• medicines called SNRIs (serotonin norepinephrine reuptake inhibitors) such as venlafaxine, duloxetine

Other medicines

• cimetidine (for indigestion or stomach ulcers)

• a quinolone antibiotic (such as ciprofloxacin)

If you are using herbal remedies containing St John’s Wort (Hypericum perforatum), side effects of Zomig Rapimelt may be more likely to happen.

Using Zomig Rapimelt with food and drink

You can take Zomig Rapimelt with or without food. It does not affect they way that Zomig Rapimelt works.

Pregnancy and breast-feeding

• It is not known if taking Zomig Rapimelt during pregnancy is harmful. Before taking Zomig Rapimelt, tell your doctor if you are pregnant or trying to become pregnant.

• Do not breast-feed within 24 hours of taking Zomig Rapimelt.

Driving and using machines

• During a migraine attack your reactions may be slower than usual. Bear this in mind when you drive or use any tools or machines.

• Zomig Rapimelt is unlikely to affect driving or using tools or machines. However, it is best to wait to see how Zomig Rapimelt affects you before you try these activities.

Important information about some of the ingredients of Zomig Rapimelt

Zomig Rapimelt orodispersible tablets contain aspartame, a source of phenylalanine, which may be harmful for people with phenylketonuria.

Always take Zomig Rapimelt exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

You can take Zomig Rapimelt as soon as a migraine headache starts.You can also take it once an attack is underway.

• The usual dose is one tablet (either 2.5 mg or 5 mg).

• Peel the blister pack open as shown on the foil. Do not push the tablet through the foil.

• Place the tablet on your tongue, where it will dissolve and be swallowed with the saliva. You do not have to take a drink of water in order to swallow your tablet.

• You can take another tablet if the migrane is still present after two hours or if it returns within 24 hours.

If the tablets did not give you enough help with your migraine, tell your doctor. Your doctor may raise the dose to 5 mg or change your treatment.

Do not use more than the dose prescribed for you.

If you take more Zomig Rapimelt than you should

If you have taken more Zomig Rapimelt than prescribed by your doctor, tell your doctor or go to the nearest hospital straight away. Take the Zomig Rapimelt medicine with you.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Zomig Rapimelt can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.

Common side effects (that affect more than 1 person in 100):

• Abnormal sensations such as tingling in your fingers and toes or skin that is sensitive to touch.

• Feeling sleepy, dizzy or warm

• Headache

• Uneven heart beat

• Feeling sick. Vomiting.

• Stomach pain

• Dry mouth

• Muscle weakness or muscle pain

• Feeling weak

• Heaviness, tightness, pain or pressure in throat, neck, arms and legs, or chest

• Difficulty in swallowing

Uncommon side effects (that affect less than 1 person in 100):

• Very fast heart beat

• Slightly higher blood pressure

• Increase in the amount of water you pass (urine) or in how often you need to pass water

Rare side effects (that affect less than 1 person in 1,000):

Very rare side effects (that affect less than 1 person in 10,000):

• Angina (pain in the chest, often brought on by exercise), heart attack or spasm of the blood vessels of the heart. If you notice chest pain or shortness of breath after taking Zomig Rapimelt, contact your doctor and do not take any more Zomig Rapimelt.

• Spasm of the blood vessels of the gut, which can cause damage to your gut. You may notice stomach pain or bloody diarrhoea. If this happens, contact your doctor and do not take any more Zomig Rapimelt.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE ZOMIG RAPIMELT

• Keep out of the reach and sight of children.

• Do not use Zomig Rapimelt after the expiry date stated on the carton. The expiry date refers to the last day of that month.

• Do not store above 30°C.

• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What Zomig Rapimelt contains

The active ingredient is zolmitriptan. Zomig Rapimelt orodispersible tablets contain either 2.5 mg or 5 mg of zolmitriptan.

The other ingredients are: aspartame E-951, citric acid anhydrous, colloidal silicon dioxide, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, orange flavour and bicarbonate.

What Zomig Rapimelt looks like and contents of the pack

• Zomig Rapimelt 2.5 mg orodispersible tablets are white, flat-faced, round and marked with the letter ‘Z’ on one side.

• Zomig Rapimelt 5 mg orodispersible tablets are white, flat-faced, round and marked with ‘Z 5’ on one side.

• Zomig Rapimelt orodispersible tablets 2.5 mg and 5 mg come in peelable aluminium laminate blister packs containing 2, 6 or 12 (2x6) tablets with or without wallet.

A wallet is a hard plastic cover which you can store your tablets in for convenience. You must keep the outer carton and this leaflet when using the wallet, as you may need to refer to them again.

Not all pack sizes may be marketed.

Zomig may also be available as nasal spray 2.5 mg/dose and 5 mg/dose and film-coated tablets 2.5 mg and 5 mg.

Marketing Authorisation Holder and Manufacturer

To be completed nationally.

This leaflet was last approved

2015-06-04